Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 4, 2011
Patent Application Number
09998250
Date Filed
November 30, 2001
Patent Primary Examiner
Patent abstract
Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
